These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17459918)

  • 1. Establishment of a cottontail rabbit papillomavirus/HLA-A2.1 transgenic rabbit model.
    Hu J; Peng X; Budgeon LR; Cladel NM; Balogh KK; Christensen ND
    J Virol; 2007 Jul; 81(13):7171-7. PubMed ID: 17459918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity with an E1 multivalent epitope DNA vaccine against cottontail rabbit papillomavirus (CRPV) infection in an HLA-A2.1 transgenic rabbit model.
    Hu J; Cladel N; Peng X; Balogh K; Christensen ND
    Vaccine; 2008 Feb; 26(6):809-16. PubMed ID: 18187239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HLA-A2.1-transgenic rabbit model to study immunity to papillomavirus infection.
    Hu J; Peng X; Schell TD; Budgeon LR; Cladel NM; Christensen ND
    J Immunol; 2006 Dec; 177(11):8037-45. PubMed ID: 17114477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine generated immunity targets an HPV16 E7 HLA-A2.1-restricted CD8(+) T cell epitope relocated to an early gene or a late gene of the cottontail rabbit papillomavirus (CRPV) genome in HLA-A2.1 transgenic rabbits.
    Bounds CE; Hu J; Cladel NM; Balogh K; Christensen ND
    Vaccine; 2011 Feb; 29(6):1194-200. PubMed ID: 21167863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits.
    Hu J; Cladel N; Balogh K; Christensen N
    Vaccine; 2010 May; 28(21):3706-13. PubMed ID: 20332046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo.
    Hu J; Cladel NM; Balogh K; Budgeon L; Christensen ND
    Virology; 2007 Feb; 358(2):384-90. PubMed ID: 17027057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.
    Hu J; Cladel NM; Budgeon LR; Reed CA; Pickel MD; Christensen ND
    Viral Immunol; 2006; 19(3):492-507. PubMed ID: 16987067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinitiated expression of EJras transgene in targeted epidermal cells of transgenic rabbits by cottontail rabbit papillomavirus infection.
    Peng X; Griffith JW; Lang CM
    Cancer Lett; 2001 Oct; 171(2):193-200. PubMed ID: 11520603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracutaneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits.
    Hu J; Han R; Cladel NM; Pickel MD; Christensen ND
    J Virol; 2002 Jul; 76(13):6453-9. PubMed ID: 12050357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.
    Schneider M; Müller M; Yigitliler A; Xi J; Simon C; Feger T; Rziha HJ; Stubenrauch F; Rammensee HG; Iftner T; Amann R
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased immunity to cottontail rabbit papillomavirus infection in EIII/JC inbred rabbits after vaccination with a mutant E6 that correlates with spontaneous regression.
    Hu J; Cladel NM; Christensen ND
    Viral Immunol; 2007; 20(2):320-5. PubMed ID: 17603848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge.
    Govan VA; Christensen ND; Berkower C; Jacobs WR; Williamson AL
    Vaccine; 2006 Mar; 24(12):2087-93. PubMed ID: 16343704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus E6 influence spontaneous regression of cutaneous papillomas.
    Hu J; Cladel NM; Pickel MD; Christensen ND
    J Virol; 2002 Dec; 76(23):11801-8. PubMed ID: 12414922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.
    Breitburd F; Kirnbauer R; Hubbert NL; Nonnenmacher B; Trin-Dinh-Desmarquet C; Orth G; Schiller JT; Lowy DR
    J Virol; 1995 Jun; 69(6):3959-63. PubMed ID: 7745754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation.
    Jansen KU; Rosolowsky M; Schultz LD; Markus HZ; Cook JC; Donnelly JJ; Martinez D; Ellis RW; Shaw AR
    Vaccine; 1995 Nov; 13(16):1509-14. PubMed ID: 8578834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.
    Christensen ND; Reed CA; Cladel NM; Han R; Kreider JW
    J Virol; 1996 Feb; 70(2):960-5. PubMed ID: 8551636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte proliferation in vitro against cottontail rabbit papillomavirus in rabbits with persisting papillomas/cancer or after regression.
    Höpfl R; hristensen ND; Angell MG; Kreider JW
    Arch Dermatol Res; 1995; 287(7):652-8. PubMed ID: 8534129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.
    Hu J; Schell TD; Peng X; Cladel NM; Balogh KK; Christensen ND
    J Vaccines Vaccin; 2010 Aug; 1(1):. PubMed ID: 21572916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.
    Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND
    J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA.
    Jensen ER; Selvakumar R; Shen H; Ahmed R; Wettstein FO; Miller JF
    J Virol; 1997 Nov; 71(11):8467-74. PubMed ID: 9343203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.